In recent years, prevalence and incidences of chronic infectious diseases as well as genetic disorders is increasing the growth of Regenerative Medicine. According to the report, the global regenerative medicine market was estimated to be over US$ 13 billion in 2019. It is anticipated to grow at a CAGR of 23.2% from 2019 to 2030.
New York, NY -- (SBWIRE) -- 04/06/2020 -- Regenerative medicine is a field of transactional research of molecular biology and tissue engineering. It deals with the procedure engineering, replacing, or regenerating animal or human cells. It also deals in the making, replacing, or changing organs and tissues to restore normal functioning. This field holds huge opportunity for establishing the functions which earlier were declared to be irreparable organs or tissues. Regenerative medicine comprises the probability of growing organs and tissues in laboratory and inserting them when the body is unable to heal. This method is expected to solve the issues organ transplant rejection and shortage of organs o tissues available for donation.
Some of the prominent players in the global regenerative medicine market include:
Integra LifeSciences Corporation,
Spark Therapeutics, Inc.,
Osiris Therapeutics, Inc.,
Organogenesis Inc. and MEDIPOST among others.
Click Here to Get Acess of Free Sample Pages @ https://www.marketindustryreports.com/pdf/254
Scope of Report:
The significant growth of the market can be attributed to increasing prevalence of chronic as well as genetic disorders followed by increasing demand of medicines and therapies that can help cure and prevent these disorders. Moreover, increasing private and government investments for research & development of regenerative medicines are anticipated to boost the regenerative medicine market over the forecast period. To obtain better insights regarding the market scenario, prominent players are increasingly focusing on mergers, acquisitions or collaborations with smaller regenerative medicine companies. For instance, in Jan 2020, Amgen announced a strategic collaboration with BeiGene a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drugs for the treatment of cancer. This strategic collaboration will enable Amgen to expand its oncology presence in China.
In recent years, prevalence and incidences of chronic infectious diseases as well as genetic disorders is increasing. For instance, according to American Cancer Society, in 2019, there were around 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States. Such high incidence rates are thus increasing the demand of medicines that can help to prevent or cure such diseases. Such factors are expected to play a pivotal role in fueling the growth of the market during the forecast period.
Regenerative Medicine Market By Type: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineering Products and Gene Therapy Products
Application: Musculoskeletal Disorders, Oncology, Ocular Disorders, Wound Care and Diabetes
To Avail Limited Offers Get Interesting Discount @ https://www.marketindustryreports.com/discount/254
Table of Contents
Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecasted Years – 2019 to 2030
Data Collection Technique
Market Estimation Methodology
Bottoms Up Approach
Top Down Approach
Data Validation and Triangulation
Market Forecasting Model
Limitations/Assumptions of the Study
ABSTRACT OF THE STUDY
MARKET DYNAMICS ASSESMENT
To Know More Information Buy this Full Report @ https://www.marketindustryreports.com/checkout/254
About Market Industry Reports
Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
Phone: +1 347 767 5477 ( US ) + 91 8956 767 535 ( IN ) + 44 131 463 4161 ( UK )